Detailed price information for Xenon Pharmaceuticals Inc (XENE-Q) from The Globe and Mail including charting and trades.
Severe liver injury cases prompt required liver function testing for patients taking the epilepsy drug as adjunctive therapy for focal seizures.
Suicidality at the time of focal epilepsy diagnosis is associated with a more than 2-fold increased risk for future antiseizure medication resistance.
Biohaven Ltd. (NYSE:BHVN) is one of the 8 Healthcare Stocks Insiders Are Buying. On April 2, 2026, Citi analyst Samantha ...
Biohaven (NYSE: BHVN) stock got quite the shot in the arm as the trading week began. On Monday, an analyst initiated coverage ...
Essential3 is the first positive Phase 3 program in essential tremor; ulixacaltamide has received FDA Breakthrough Therapy Designation, with data selected for plenary presentation at AAN 2026 Praxis ...
For pediatric patients with drug-resistant focal epilepsy, stereoelectroencephalography-guided radiofrequency ...
Detailed price information for Xenon Pharmaceuticals Inc (XENE-Q) from The Globe and Mail including charting and trades.
Suicidality at the time of a focal epilepsy diagnosis was associated with a higher risk for future treatment resistance to antiseizure medications (ASMs), independent of concurrent mood or anxiety ...
For pediatric patients with drug-resistant focal epilepsy, stereoelectroencephalography-guided radiofrequency ...
Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results